Tyra Biosciences Inc (TYRA)

Currency in USD
11.01
-0.10(-0.92%)
Real-time Data·
TYRA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 9 days
Fair Value
Day's Range
10.7111.16
52 wk Range
6.4229.60
Key Statistics
Prev. Close
11.11
Open
11.16
Day's Range
10.71-11.16
52 wk Range
6.42-29.6
Volume
59.23K
Average Volume (3m)
331.83K
1-Year Change
-44.7%
Book Value / Share
6.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TYRA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.14
Upside
+173.78%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Tyra Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Tyra Biosciences Inc Company Profile

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Compare TYRA to Peers and Sector

Metrics to compare
TYRA
Peers
Sector
Relationship
P/E Ratio
−6.0x−4.1x−0.5x
PEG Ratio
−2.840.030.00
Price/Book
1.8x3.7x2.6x
Price / LTM Sales
-9.4x3.2x
Upside (Analyst Target)
171.2%202.7%41.2%
Fair Value Upside
Unlock12.4%6.2%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.14
(+173.78% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.47 / -0.48
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TYRA Income Statement

People Also Watch

16.67
SRPT
+20.28%
3.70
REPL
+16.56%
113.19
DECK
+0.71%
729.54
AXON
-0.92%
12.91
BHVN
-1.07%

FAQ

What Stock Exchange Does Tyra Biosciences Trade On?

Tyra Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tyra Biosciences?

The stock symbol for Tyra Biosciences is "TYRA."

What Is the Tyra Biosciences Market Cap?

As of today, Tyra Biosciences market cap is 590.81M.

What Is Tyra Biosciences's Earnings Per Share (TTM)?

The Tyra Biosciences EPS (TTM) is -1.63.

When Is the Next Tyra Biosciences Earnings Date?

Tyra Biosciences will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is TYRA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tyra Biosciences Stock Split?

Tyra Biosciences has split 0 times.

How Many Employees Does Tyra Biosciences Have?

Tyra Biosciences has 60 employees.

What is the current trading status of Tyra Biosciences (TYRA)?

As of 29 Jul 2025, Tyra Biosciences (TYRA) is trading at a price of 11.01, with a previous close of 11.11. The stock has fluctuated within a day range of 10.71 to 11.16, while its 52-week range spans from 6.42 to 29.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.